Nationwide study of health practitioners, first responders examines use of anti-malarial drug to counter COVID-19

Sarah Lofgren’s voice had a tinge of excitement when she explained why the bright green dots on one scientific slide disappeared on the next. The co-investigator at the University of Minnesota Division of Infectious Disease and International Medicine showed how SARS, or severe acute respiratory syndrome, represented by those green dots, responded to all the drugs that were thrown at it to determine what could hinder the virus.